In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors

Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn’s disease. T cells activation can be suppressed eith...

Full description

Saved in:
Bibliographic Details
Main Authors: Halim Sobia Ahsan, Zaheer-Ul-Haq, Khan Ajmal, Al-Rawahi Ahmed, Al-Harrasi Ahmed
Format: Article
Language:English
Published: Sciendo 2021-03-01
Series:Acta Pharmaceutica
Subjects:
Online Access:https://doi.org/10.2478/acph-2021-0002
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832572494431649792
author Halim Sobia Ahsan
Zaheer-Ul-Haq
Khan Ajmal
Al-Rawahi Ahmed
Al-Harrasi Ahmed
author_facet Halim Sobia Ahsan
Zaheer-Ul-Haq
Khan Ajmal
Al-Rawahi Ahmed
Al-Harrasi Ahmed
author_sort Halim Sobia Ahsan
collection DOAJ
description Interleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn’s disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This study was carried out to set up an effective virtual screening (VS) pipeline for IL-2. Four docking/scoring approaches (FRED, MOE, GOLD and Surflex-Dock) were compared in the re-docking process to test their performance in producing correct binding modes of IL-2 inhibitors. Surflex-Dock and FRED were the best in predicting the native pose in its top-ranking position. Shapegauss and CGO scoring functions identified the known inhibitors of IL-2 in top 1, 5 and 10 % of library and differentiated binders from non-binders efficiently with average AUC of > 0.9 and > 0.7, resp. The applied docking protocol served as a basis for the VS of a large database that will lead to the identification of more active compounds against IL-2.
format Article
id doaj-art-8a820464495a4081b33104be5b579455
institution Kabale University
issn 1846-9558
language English
publishDate 2021-03-01
publisher Sciendo
record_format Article
series Acta Pharmaceutica
spelling doaj-art-8a820464495a4081b33104be5b5794552025-02-02T09:44:23ZengSciendoActa Pharmaceutica1846-95582021-03-01711335610.2478/acph-2021-0002acph-2021-0002In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitorsHalim Sobia Ahsan0Zaheer-Ul-Haq1Khan Ajmal2Al-Rawahi Ahmed3Al-Harrasi Ahmed4Natural and Medical Science Research Center, University of Nizwa Birkat-ul-Mouz616, Nizwa Sultanate of OmanDr. Panjwani Center for Molecular Medicine and Drug Research International Center for Chemical and Biological Sciences, University of Karachi, 75270Karachi, PakistanNatural and Medical Science Research Center, University of Nizwa Birkat-ul-Mouz616, Nizwa Sultanate of OmanNatural and Medical Science Research Center, University of Nizwa Birkat-ul-Mouz616, Nizwa Sultanate of OmanNatural and Medical Science Research Center, University of Nizwa Birkat-ul-Mouz616, Nizwa Sultanate of OmanInterleukin-2 (IL-2) is involved in the activation and differentiation of T-helper cells. Uncontrolled activated T cells play a key role in the pathophysiology by stimulating inflammation and autoimmune diseases like arthritis, psoriasis and Crohn’s disease. T cells activation can be suppressed either by preventing IL-2 production or blocking the IL-2 interaction with its receptor. Hence, IL-2 is now emerging as a target for novel therapeutic approaches in several autoimmune disorders. This study was carried out to set up an effective virtual screening (VS) pipeline for IL-2. Four docking/scoring approaches (FRED, MOE, GOLD and Surflex-Dock) were compared in the re-docking process to test their performance in producing correct binding modes of IL-2 inhibitors. Surflex-Dock and FRED were the best in predicting the native pose in its top-ranking position. Shapegauss and CGO scoring functions identified the known inhibitors of IL-2 in top 1, 5 and 10 % of library and differentiated binders from non-binders efficiently with average AUC of > 0.9 and > 0.7, resp. The applied docking protocol served as a basis for the VS of a large database that will lead to the identification of more active compounds against IL-2.https://doi.org/10.2478/acph-2021-0002il-2virtual screeningfredmoegoldsurflex-dockroc-curves
spellingShingle Halim Sobia Ahsan
Zaheer-Ul-Haq
Khan Ajmal
Al-Rawahi Ahmed
Al-Harrasi Ahmed
In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
Acta Pharmaceutica
il-2
virtual screening
fred
moe
gold
surflex-dock
roc-curves
title In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
title_full In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
title_fullStr In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
title_full_unstemmed In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
title_short In silico data mining of large-scale databases for the virtual screening of human interleukin-2 inhibitors
title_sort in silico data mining of large scale databases for the virtual screening of human interleukin 2 inhibitors
topic il-2
virtual screening
fred
moe
gold
surflex-dock
roc-curves
url https://doi.org/10.2478/acph-2021-0002
work_keys_str_mv AT halimsobiaahsan insilicodataminingoflargescaledatabasesforthevirtualscreeningofhumaninterleukin2inhibitors
AT zaheerulhaq insilicodataminingoflargescaledatabasesforthevirtualscreeningofhumaninterleukin2inhibitors
AT khanajmal insilicodataminingoflargescaledatabasesforthevirtualscreeningofhumaninterleukin2inhibitors
AT alrawahiahmed insilicodataminingoflargescaledatabasesforthevirtualscreeningofhumaninterleukin2inhibitors
AT alharrasiahmed insilicodataminingoflargescaledatabasesforthevirtualscreeningofhumaninterleukin2inhibitors